Axel Sjöblad commenting on Q3 2017

Axel Sjöblad, Managing Director of BioGaia AB, summarizes the third quarter of 2017 and answers questions regarding:

• Net sales in Q3 by 17% and operating profit strengthened compared with the same period previous year.
• Sales for Adult Health were strong and increased 58% Y/Y.
• The reason behind the strong improvement in Americas.
• The situation in Italy.
• A number of distribution agreements that are now beginning to come into effect.
• BioGaia is shareholder in MetaboGen.

Listen to telephone conference from 25 October 2017 about Interim report 1 January-30 September 2017